PharmaResources (Shanghai) Co., Ltd.’s (SZSE:301230) largest shareholders are private companies who were rewarded as market cap surged CN¥300m last week
Key Insights Significant control over PharmaResources (Shanghai) by private companies implies that the general public has more power to influence management and governance-related...
Stocks, US yields climb after inflation data
A gauge of global stocks was set to snap a two-session fall on Tuesday, rising along with Treasury yields after data showed U.S. inflation...
‘Of Course I’m Going to Open a British ISA,’ Fund…
Ollie Smith: Collecting tonight's Morningstar Fund Award for Best UK Equity Fund is Warren Shiels from Man GLG.
Warren, I have to ask you, we're...
TikTok Plans Legal Fight If US Divestment Bill Becomes Law
TikTok intends to exhaust all legal challenges before it considers any kind of divestiture from Chinese parent company ByteDance Ltd. if the latest US...
FTSE 100 Live: UK GDP in focus after index closes up 1% to 2024 high
Markets are digesting what the latest jobs and wages figures mean for the prospect of interest rate cuts, as ONS figures showed unemployment ticked...
